Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design

European Journal of Medicinal Chemistry

Volumn 49, Issue , 2012, Pages 110-117

  Carbone, C ^a   Tomasello, B ^a   Ruozi, B ^b   Renis, M ^a   Puglisi, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Cetyl palmitate; DOTAP; Factorial planning; Phase inversion temperature; S.L.N.; Zeta potential

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CETRIMIDE; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; HYDROGENATED CASTOR OIL; NANOCARRIER; SOLID LIPID NANOPARTICLE;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ASTROCYTE; CELL STRAIN DU 145; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DILUTION; FACTORIAL DESIGN; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LIPOPHILICITY; MOLECULAR INTERACTION; NONHUMAN; PARTICLE SIZE; PHASE INVERSION TEMPERATURE SYNTHESIS; PHYSICAL CHEMISTRY; PREDICTIVE VALUE; SYNTHESIS; TUMOR CELL LINE; VALIDITY; ZETA POTENTIAL;

ANIMALS; ASTROCYTES; CATIONS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CETRIMONIUM COMPOUNDS; DRUG CARRIERS; FATTY ACIDS, MONOUNSATURATED; HUMANS; LIPIDS; MODELS, STATISTICAL; NANOPARTICLES; NANOTECHNOLOGY; PALMITATES; PARTICLE SIZE; QUATERNARY AMMONIUM COMPOUNDS; RATS;

EID: 84857239428     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.01.001     Document Type: Article

References (35)

1. E. Vighi, B. Ruozi, M. Montanari, R. Battini, and E. Leo pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles Int. J. Pharm. 389 2010 254 261
2. A. del Pozo-Rodrigue, D. Delgado, M.A. Solinis, A.R. Gascn, and J.L. Pedraz Solid lipid nanoparticles: formulation factors affecting cell transfection capacity Int. J. Pharm. 339 2007 261 268 (Pubitemid 46977611)
3. L. Hyndman, J.L. Lemoine, L. Huang, D.J. Porteous, A.C. Boyd, and X. Nan HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes J. Control. Rel. 99 2004 435 444 (Pubitemid 39296912)
4. M. Tokunaga, N. Hazemoto, and T. Yotsuyanagi Effect of oligopeptides on gene expression: comparison of DNA/peptide and DNA/peptide/liposome complexes Int. J. Pharm. 269 2004 71 80 (Pubitemid 38032824)
5. N. Pedersen, S. Hansen, A.V. Heydenreich, H.G. Kristensen, and H.S. Poulsen Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands Eur. J. Pharm. Biopharm. 62 2006 155 162 (Pubitemid 43143267)
6. N. Anton, and T.F. Vandamme The universality of low-energy nano-emulsification Int. J. Pharm. 377 2009 142 147
7. Z. Mei, S. Liu, L. Wang, J. Jang, J. Xu, and D. Sun Preparation of positively charged oil/water nano-emulsions with a sub-PIT method J. Coll. Int. Sci. 361 2011 565 572
8. N. Anton, P. Gayet, J.P. Benoit, and P. Saulnier Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion Int. J. Pharm. 344 2007 44 52 (Pubitemid 47495984)
9. G. Box, and K.B. Wilson On the experimental attainment of optimum conditions J. R. Stat. Soc. Ser. B. Methodol. 13 1951 1 45
10. M.D. Bahavsar, S.B. Tiwari, and M.M. Amiji Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design J. Contr. Rel. 110 2006 422 430 (Pubitemid 41827496)
11. C. Vitorino, F.A. Carvalho, A.J. Almeida, J.J. Sousa, and A.A.C.C. Pais The size of solid lipid nanoparticles: an interpretation from experimental design Coll. Surf. B. 84 2011 117 130
12. L. Montenegro, C. Carbone, G. Condorelli, R. Drago, and G. Puglisi Effect of oil phase lipophilicity on in vitro drug release from o/w microemulsion with low surfactant content Drug Dev. Ind. Pharm. 32 2006 539 548 (Pubitemid 43982404)
13. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63 (Pubitemid 14203433)
14. G. Lukowski, J. Kasbohm, P. Pflegel, A. Illing, and H. Wulff Crystallographic investigation of cetylpalmitate solid lipid nanoparticles Int. J. Pharm. 196 2000 201 220
15. J.J. Wang, K.S. Liu, K.C. Sung, C.Y. Tsai, and J.Y. Fang Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection Eur. J. Pharm. Sci. 38 2009 138 146
16. R. Yang, R. Gao, F. Li, H. He, and X. Tang The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process Drug Dev. Ind. Pharm. 37 2011 139 148
17. P. Izquierdo, J. Feng, J. Esqueda, T.F. Tadros, J.C. Dederen, M.J. Garcia, N. Azemr, and C. Solans The inflence of surfactant mixing ratio on nano-emulsion formation by the PIT method J. Coll. Int. Sci. 285 2005 388 394 (Pubitemid 41350451)
18. D. Doroud, A. Vatanara, F. Zahedifard, E. Gholami, R. Vahabpour, A.R. Najafabadi, and S. Rfati Cationic solid lipid nanoparticles loaded by cystein proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations J. Pharm. Pharm. Sci. 13 2010 320 335
19. M.L. Bond, A. Azzolina, E.F. Craparo, N. Lampiasi, G. Capuano, G. Giammona, and M. Cervello Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery J. Drug Target. 15 2007 295 301 (Pubitemid 47161496)
20. J.S. Chang, Y.P. Lee, and R.C. Wang Optimization of Nanosized Silver particle Synthesis via experimental design Ind. Eng. Chem. Res. 46 2007 5591 5599
21. S. Singh, A.K. Dobahl, A. Jain, J.K. Pandit, and S. Chakraborty Formulation and Evaluation of Solid Lipid Nanoparticles of a Water Soluble Drug: Zidovudine vol. 58 2010 Chem. Pharm. Bull Tokyo 650-655
22. R. Tiwari, and K. Pathak Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake Int. J. Pharm. 415 2011 232 243
23. M. Shah, K. Chuttani, A.K. Misrh, and K. Patrak Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies Drug Dev. Ind. Pharm. 37 2011 526 537
24. E. Gonzalez-Mira, M.A. Egea, E.B. Souto, A.C. Calpena, and M.L. Garca Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery Nanotechnology 22 2011 045101
25. K. Tabatt, M. Sameti, C. Olbrich, R.H. Muller, and C.M. Lehr Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticles- mediated gene transfer Eur. J. Pharm. Biopharm. 57 2004 155 162 (Pubitemid 38283690)
26. W. Mehnert, and K. Mader Solid lipid nanoparticles: production, characterization and application Adv. Drug Deliv. Rev. 47 2001 165 196 (Pubitemid 32324113)
27. M. Trotta, F. Debernardi, and O. Caputo Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique Int. J. Pharm. 257 2003 153 160 (Pubitemid 36507041)
28. R.K. Subedi, K.W. Kang, and H.K. Choi Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin Eur. J. Pharm. Sci. 37 2009 508 513
29. D. Simberg, S. Weisman, Y. Talmon, and Y. Barenholz DOTAP (and other cationic lipids): chemistry, biophysics, and transfection Crit. Rev. Ther. Drug Carrier Syst. 21 2004 257 317 (Pubitemid 41647579)
30. S. Kaech, J.B. Kim, M. Cariola, and E. Ralston Improved lipid-mediated gene transfer into primary cultures of hippocampal neurons Brain Res. Mol. Brain Res. 35 1996 344 348 (Pubitemid 26036767)
31. M.T. da Cruz, S. Simoes, and M.C. de Lima Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons Exp. Neurol. 187 2004 65 75 (Pubitemid 38470013)
32. M. Favrot, J.L. Coll, N. Louis, and A. Negoescu Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapy Gene Ther. 5 1998 728 739 (Pubitemid 28321006)
33. L. Pan, X.C. Peng, F. Leng, Q.Z. Yuan, Y. Shan, D.D. Yu, Z.Y. Li, X. Chen, W.J. Xiao, Y. Wen, T.T. Ma, L. Yang, Y.Q. Mao, H.S. Yang, Y.Q. Wei, and C.T. Wang Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer J. Cancer Res. Clin. Oncol. 137 2011 19 28
34. M.B. de Jesus, C.V. Ferreira, E. de Paula, D. Hoekstra, and I.S. Zuhor Design of solid lipid nanoparticles for gene delivery into prostate cancer J. Contr. Rel 148 2010 e89 e90
35. F. Corrias, and F. Lai New methods for lipid nanoparticles preparation Recent Pat. Drug Deliv. Formul. 5 2011 201 213